Log in

NYSE:PBH - Prestige Consumer Healthcare Stock Price, Forecast & News

$36.40
+1.25 (+3.56 %)
(As of 03/29/2020 02:13 PM ET)
Today's Range
$33.86
Now: $36.40
$37.22
50-Day Range
$29.50
MA: $38.07
$45.96
52-Week Range
$27.40
Now: $36.40
$46.12
Volume480,554 shs
Average Volume910,667 shs
Market Capitalization$1.83 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.89
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning. The company's OTC healthcare products include BC/Goody's analgesic powders, Beano for gas prevention, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids/lozenges, Clear Eyes for eye allergy/redness relief, Compound W for wart removal, Debrox for ear wax removal, DenTek PEG oral care, Dramamine for motion sickness relief, and Efferdent denture cleanser tablets. Its OTC healthcare products portfolio also comprises Fess nasal saline spray, Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Hydralyte for oral rehydration, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Pedia-Lax pediatric laxatives, Summer's Eve for feminine hygiene, Little Remedies pediatric OTC products, and The Doctor's NightGuard dental protectors. In addition, the company offers household cleaning products, such as abrasive tub and tile cleaners under the Comet name, as well as Chore Boy, and Spic and Span names. It serves mass merchandisers; and drug, food, dollar, convenience, and club stores. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Read More
Prestige Consumer Healthcare logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPersonal Products
SectorConsumer Discretionary
CUSIP74112D10
Phone914-524-6800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$975.78 million
Cash Flow$3.67 per share
Book Value$21.16 per share

Profitability

Net Income$-35,800,000.00

Miscellaneous

Employees530
Market Cap$1.83 billion
Next Earnings Date5/14/2020 (Estimated)
OptionableOptionable

Receive PBH News and Ratings via Email

Sign-up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter.


Prestige Consumer Healthcare (NYSE:PBH) Frequently Asked Questions

How has Prestige Consumer Healthcare's stock been impacted by COVID-19 (Coronavirus)?

Prestige Consumer Healthcare's stock was trading at $35.91 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PBH stock has increased by 1.4% and is now trading at $36.40. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Prestige Consumer Healthcare?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Prestige Consumer Healthcare.

When is Prestige Consumer Healthcare's next earnings date?

Prestige Consumer Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for Prestige Consumer Healthcare.

How were Prestige Consumer Healthcare's earnings last quarter?

Prestige Consumer Healthcare Inc (NYSE:PBH) posted its quarterly earnings data on Thursday, February, 6th. The company reported $0.81 EPS for the quarter, topping analysts' consensus estimates of $0.75 by $0.06. The company earned $241.60 million during the quarter, compared to analyst estimates of $240.34 million. Prestige Consumer Healthcare had a positive return on equity of 13.17% and a negative net margin of 3.57%. Prestige Consumer Healthcare's quarterly revenue was up .1% compared to the same quarter last year. During the same period in the previous year, the business posted $0.73 earnings per share. View Prestige Consumer Healthcare's earnings history.

What guidance has Prestige Consumer Healthcare issued on next quarter's earnings?

Prestige Consumer Healthcare issued an update on its FY20 earnings guidance on Thursday, February, 6th. The company provided earnings per share (EPS) guidance of $2.85-2.87 for the period, compared to the Thomson Reuters consensus estimate of $2.82. The company issued revenue guidance of $947-957 million, compared to the consensus revenue estimate of $950.04 million.

What price target have analysts set for PBH?

5 brokerages have issued 1 year price targets for Prestige Consumer Healthcare's stock. Their forecasts range from $43.00 to $106.00. On average, they anticipate Prestige Consumer Healthcare's stock price to reach $77.67 in the next year. This suggests a possible upside of 113.4% from the stock's current price. View analysts' price targets for Prestige Consumer Healthcare.

Has Prestige Consumer Healthcare been receiving favorable news coverage?

Headlines about PBH stock have been trending extremely negative on Sunday, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Prestige Consumer Healthcare earned a media sentiment score of -4.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutPrestige Consumer Healthcare.

Are investors shorting Prestige Consumer Healthcare?

Prestige Consumer Healthcare saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 7,734,200 shares, an increase of 5.1% from the February 27th total of 7,360,000 shares. Based on an average trading volume of 391,700 shares, the short-interest ratio is currently 19.7 days. Currently, 15.5% of the company's stock are short sold. View Prestige Consumer Healthcare's Current Options Chain.

Who are some of Prestige Consumer Healthcare's key competitors?

What other stocks do shareholders of Prestige Consumer Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include Gilead Sciences (GILD), AbbVie (ABBV), Edwards Lifesciences (EW), AT&T (T), Cara Therapeutics (CARA), GW Pharmaceuticals PLC- (GWPH), Rigel Pharmaceuticals (RIGL), Boeing (BA), IBM (IBM) and Johnson & Johnson (JNJ).

Who are Prestige Consumer Healthcare's key executives?

Prestige Consumer Healthcare's management team includes the following people:
  • Mr. Ronald M. Lombardi, Chairman, Pres & CEO (Age 55)
  • Ms. Christine Sacco, Chief Financial Officer (Age 43)
  • Mr. William C. P'Pool, Sr. VP, Gen. Counsel & Corp. Sec. (Age 54)
  • Mr. Timothy J. Connors, Exec. VP of Sales & Marketing (Age 52)
  • Mr. Jeff Zerillo, Sr. VP of Operations

What is Prestige Consumer Healthcare's stock symbol?

Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

Who are Prestige Consumer Healthcare's major shareholders?

Prestige Consumer Healthcare's stock is owned by a number of retail and institutional investors. Top institutional investors include Champlain Investment Partners LLC (4.73%), Macquarie Group Ltd. (3.98%), Macquarie Group Ltd. (3.98%), FMR LLC (3.79%), ArrowMark Colorado Holdings LLC (3.70%) and State Street Corp (3.54%). Company insiders that own Prestige Consumer Healthcare stock include Jean A Boyko, Paton Brett and Timothy Connors. View institutional ownership trends for Prestige Consumer Healthcare.

Which institutional investors are selling Prestige Consumer Healthcare stock?

PBH stock was sold by a variety of institutional investors in the last quarter, including ArrowMark Colorado Holdings LLC, Goldman Sachs Group Inc., Acadian Asset Management LLC, State of Tennessee Treasury Department, Prudential Financial Inc., Lapides Asset Management LLC, Oxford Asset Management LLP, and Skyline Asset Management LP. View insider buying and selling activity for Prestige Consumer Healthcare.

Which institutional investors are buying Prestige Consumer Healthcare stock?

PBH stock was purchased by a variety of institutional investors in the last quarter, including Norges Bank, Macquarie Group Ltd., Macquarie Group Ltd., Champlain Investment Partners LLC, Wedge Capital Management L L P NC, Man Group plc, Peregrine Capital Management LLC, and Massachusetts Financial Services Co. MA. View insider buying and selling activity for Prestige Consumer Healthcare.

How do I buy shares of Prestige Consumer Healthcare?

Shares of PBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Prestige Consumer Healthcare's stock price today?

One share of PBH stock can currently be purchased for approximately $36.40.

How big of a company is Prestige Consumer Healthcare?

Prestige Consumer Healthcare has a market capitalization of $1.83 billion and generates $975.78 million in revenue each year. The company earns $-35,800,000.00 in net income (profit) each year or $2.78 on an earnings per share basis. Prestige Consumer Healthcare employs 530 workers across the globe. View additional information about Prestige Consumer Healthcare.

What is Prestige Consumer Healthcare's official website?

The official website for Prestige Consumer Healthcare is http://www.prestigebrands.com/.

How can I contact Prestige Consumer Healthcare?

Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The company can be reached via phone at 914-524-6800 or via email at [email protected]


MarketBeat Community Rating for Prestige Consumer Healthcare (NYSE PBH)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  457 (Vote Outperform)
Underperform Votes:  338 (Vote Underperform)
Total Votes:  795
MarketBeat's community ratings are surveys of what our community members think about Prestige Consumer Healthcare and other stocks. Vote "Outperform" if you believe PBH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PBH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel